Trial Profile
A randomized controlled double blind trial to study the effects of dexmedetomidine in cleft palate surgeries
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam
- Indications Intraoperative pain
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms DEXCP
- 07 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 18 Feb 2014 New trial record